中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Synthesis and enantioselective hydrogenation of seven-membered cyclic imines: substituted dibenzo[b,f][1,4]oxazepines

文献类型:期刊论文

作者Gao, Kai1; Yu, Chang-Bin1; Li, Wei2; Zhou, Yong-Gui1; Zhang, Xumu2
刊名chemical communications
出版日期2011
卷号47期号:27页码:7845-7847
ISSN号待补充
产权排序1,1
通讯作者周永贵 ; 张绪穆
中文摘要synthesis and enantioselective hydrogenation of seven-membered cyclic imines: substituted dibenzo[b,f][1,4]oxazepines
英文摘要highly enantioselective hydrogenation of seven-membered cyclic imines, substituted dibenzo[b,f][1,4]oxazepines, was achieved, with up to 94% ee, by using the [ir(cod)cl](2)/(s)-xyl-c(3)(*)-tunephos complex as the catalyst in the presence of morpholine-hcl.
WOS标题词science & technology ; physical sciences
学科主题物理化学
类目[WOS]chemistry, multidisciplinary
研究领域[WOS]chemistry
关键词[WOS]catalyzed asymmetric hydrogenation ; hiv-1 reverse-transcriptase ; n-aryl imines ; heteroaromatic-compounds ; quinoline derivatives ; iridium complexes ; acyclic imines ; ligands ; inhibitors ; ketimines
收录类别SCI ; IC ; CCR
语种英语
WOS记录号WOS:000292113700085
公开日期2012-07-09
源URL[http://159.226.238.44/handle/321008/115411]  
专题大连化学物理研究所_中国科学院大连化学物理研究所
作者单位1.Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian 116023, Peoples R China
2.Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA
推荐引用方式
GB/T 7714
Gao, Kai,Yu, Chang-Bin,Li, Wei,et al. Synthesis and enantioselective hydrogenation of seven-membered cyclic imines: substituted dibenzo[b,f][1,4]oxazepines[J]. chemical communications,2011,47(27):7845-7847.
APA Gao, Kai,Yu, Chang-Bin,Li, Wei,Zhou, Yong-Gui,&Zhang, Xumu.(2011).Synthesis and enantioselective hydrogenation of seven-membered cyclic imines: substituted dibenzo[b,f][1,4]oxazepines.chemical communications,47(27),7845-7847.
MLA Gao, Kai,et al."Synthesis and enantioselective hydrogenation of seven-membered cyclic imines: substituted dibenzo[b,f][1,4]oxazepines".chemical communications 47.27(2011):7845-7847.

入库方式: OAI收割

来源:大连化学物理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。